Pennant Debt to Equity Ratio 2018-2026 | PNTG
Current and historical debt to equity ratio values for Pennant (PNTG) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Pennant debt/equity for the three months ending June 30, 2026 was 0.48.
| Pennant Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $0.63B | $0.40B | 1.57 |
| 2026-03-31 | $0.57B | $0.39B | 1.46 |
| 2025-12-31 | $0.59B | $0.37B | 1.59 |
| 2025-09-30 | $0.41B | $0.34B | 1.20 |
| 2025-06-30 | $0.42B | $0.33B | 1.25 |
| 2025-03-31 | $0.42B | $0.32B | 1.30 |
| 2024-12-31 | $0.37B | $0.31B | 1.18 |
| 2024-09-30 | $0.46B | $0.19B | 2.45 |
| 2024-06-30 | $0.43B | $0.17B | 2.48 |
| 2024-03-31 | $0.41B | $0.16B | 2.52 |
| 2023-12-31 | $0.39B | $0.15B | 2.71 |
| 2023-09-30 | $0.38B | $0.14B | 2.73 |
| 2023-06-30 | $0.38B | $0.13B | 2.86 |
| 2023-03-31 | $0.38B | $0.13B | 2.93 |
| 2022-12-31 | $0.39B | $0.13B | 3.08 |
| 2022-09-30 | $0.38B | $0.12B | 3.18 |
| 2022-06-30 | $0.38B | $0.12B | 3.21 |
| 2022-03-31 | $0.39B | $0.12B | 3.30 |
| 2021-12-31 | $0.42B | $0.11B | 3.64 |
| 2021-09-30 | $0.42B | $0.11B | 3.65 |
| 2021-06-30 | $0.42B | $0.11B | 3.82 |
| 2021-03-31 | $0.42B | $0.11B | 3.96 |
| 2020-12-31 | $0.41B | $0.10B | 4.01 |
| 2020-09-30 | $0.39B | $0.09B | 4.37 |
| 2020-06-30 | $0.39B | $0.08B | 4.69 |
| 2020-03-31 | $0.38B | $0.08B | 5.03 |
| 2019-12-31 | $0.38B | $0.07B | 5.30 |
| 2019-09-30 | $0.28B | $0.08B | 3.30 |
| 2019-06-30 | $0.00B | $0.00B | 0.00 |
| 2019-03-31 | $0.00B | $0.00B | 0.00 |
| 2018-12-31 | $0.00B | 0.00 | |
| 2018-09-30 | $0.00B | $0.00B | 0.00 |
| 2017-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.396B | $0.948B |
| The Pennant Group Inc. through subsidiaries offers home health, hospice and senior living services. It operates primarily in Arizona, California, Colorado, Idaho, Iowa, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. The Pennant Group Inc. is based in Eagle, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |